Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group. Duffield-Lillico AJ, et al. Among authors: clark lc. BJU Int. 2003 May;91(7):608-12. doi: 10.1046/j.1464-410x.2003.04167.x. BJU Int. 2003. PMID: 12699469 Clinical Trial.
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, Slate E, Hsu CH, Dalkin BL, Sindhwani P, Holmes MA, Tuckey JA, Graham DL, Parnes HL, Clark LC, Stratton SP. Algotar AM, et al. Among authors: clark lc. Prostate. 2013 Feb 15;73(3):328-35. doi: 10.1002/pros.22573. Epub 2012 Aug 10. Prostate. 2013. PMID: 22887343 Free PMC article. Clinical Trial.
Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC. Duffield-Lillico AJ, et al. Among authors: clark lc. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):630-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12101110 Clinical Trial.
Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group. Duffield-Lillico AJ, et al. Among authors: clark lc. J Natl Cancer Inst. 2003 Oct 1;95(19):1477-81. doi: 10.1093/jnci/djg061. J Natl Cancer Inst. 2003. PMID: 14519754 Clinical Trial.
The nutritional prevention of cancer: 400 mcg per day selenium treatment.
Reid ME, Duffield-Lillico AJ, Slate E, Natarajan N, Turnbull B, Jacobs E, Combs GF Jr, Alberts DS, Clark LC, Marshall JR. Reid ME, et al. Among authors: clark lc. Nutr Cancer. 2008;60(2):155-63. doi: 10.1080/01635580701684856. Nutr Cancer. 2008. PMID: 18444146 Clinical Trial.
Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
Stratton MS, Algotar AM, Ranger-Moore J, Stratton SP, Slate EH, Hsu CH, Thompson PA, Clark LC, Ahmann FR. Stratton MS, et al. Among authors: clark lc. Cancer Prev Res (Phila). 2010 Aug;3(8):1035-43. doi: 10.1158/1940-6207.CAPR-09-0143. Epub 2010 Jul 20. Cancer Prev Res (Phila). 2010. PMID: 20647337 Free PMC article. Clinical Trial.
Selenium and prostate cancer prevention.
Nelson MA, Porterfield BW, Jacobs ET, Clark LC. Nelson MA, et al. Among authors: clark lc. Semin Urol Oncol. 1999 May;17(2):91-6. Semin Urol Oncol. 1999. PMID: 10332922 Review.
230 results